Another miRNA, miR-34a, has been reported to noticeably inhibit the expression of DLL1, trigger cell death and senescence, suppress proliferation, and prevent scratch assay wound closure in rat chondrocytes and chondrosarcoma cells, therefore facilitating the development of OA [46]. The gene discussed is DLL1; the disease is chondrosarcoma.